ABM International Limited (NSE:ABMINTLLTD)
India · Delayed Price · Currency is INR 59.21
-0.19 (-0.32%)
Aug 1, 2025, 2:14 PM IST
CTI BioPharma Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 801.93 | 936.44 | 853.73 | 1,270 | 1,286 | Upgrade | |
Revenue Growth (YoY) | -14.36% | 9.69% | -32.77% | -1.27% | 31.63% | Upgrade |
Cost of Revenue | 812.52 | 970.17 | 935.36 | 1,211 | 1,163 | Upgrade |
Gross Profit | -10.59 | -33.73 | -81.63 | 59.27 | 123.17 | Upgrade |
Selling, General & Admin | 5.64 | 6.96 | 8.73 | 8.85 | 7.89 | Upgrade |
Other Operating Expenses | 5.12 | 4.03 | 6.13 | 30.86 | 4.64 | Upgrade |
Operating Expenses | 11.07 | 11.38 | 15.34 | 40.31 | 13.22 | Upgrade |
Operating Income | -21.66 | -45.12 | -96.97 | 18.97 | 109.95 | Upgrade |
Interest Expense | -2.03 | -4.5 | -0.1 | -0.37 | -0.22 | Upgrade |
Interest & Investment Income | - | 1.8 | 1.7 | 1.99 | 1.84 | Upgrade |
Earnings From Equity Investments | -0.08 | 0.19 | -0.13 | -0.17 | -0.1 | Upgrade |
Other Non Operating Income (Expenses) | 5.09 | 1.88 | 1.82 | 1.46 | 6.19 | Upgrade |
EBT Excluding Unusual Items | -18.68 | -45.75 | -93.68 | 21.88 | 117.66 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | 5.82 | 0.43 | 0.95 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 0.19 | - | Upgrade |
Pretax Income | -18.68 | -45.75 | -87.86 | 22.5 | 118.61 | Upgrade |
Income Tax Expense | -5.03 | -11.64 | -20.87 | 8.78 | 17.05 | Upgrade |
Net Income | -13.64 | -34.11 | -66.99 | 13.72 | 101.56 | Upgrade |
Net Income to Common | -13.64 | -34.11 | -66.99 | 13.72 | 101.56 | Upgrade |
Net Income Growth | - | - | - | -86.49% | - | Upgrade |
Shares Outstanding (Basic) | 10 | 9 | 9 | 9 | 9 | Upgrade |
Shares Outstanding (Diluted) | 10 | 9 | 9 | 9 | 9 | Upgrade |
Shares Change (YoY) | 2.85% | - | - | - | - | Upgrade |
EPS (Basic) | -1.41 | -3.63 | -7.12 | 1.46 | 10.79 | Upgrade |
EPS (Diluted) | -1.41 | -3.63 | -7.12 | 1.46 | 10.79 | Upgrade |
EPS Growth | - | - | - | -86.49% | - | Upgrade |
Free Cash Flow | -12.36 | -96.2 | -117.4 | 33.33 | 51.72 | Upgrade |
Free Cash Flow Per Share | -1.28 | -10.22 | -12.48 | 3.54 | 5.50 | Upgrade |
Gross Margin | -1.32% | -3.60% | -9.56% | 4.67% | 9.58% | Upgrade |
Operating Margin | -2.70% | -4.82% | -11.36% | 1.49% | 8.55% | Upgrade |
Profit Margin | -1.70% | -3.64% | -7.85% | 1.08% | 7.90% | Upgrade |
Free Cash Flow Margin | -1.54% | -10.27% | -13.75% | 2.63% | 4.02% | Upgrade |
EBITDA | -21.35 | -44.72 | -96.47 | 19.56 | 110.65 | Upgrade |
EBITDA Margin | -2.66% | -4.78% | -11.30% | 1.54% | 8.60% | Upgrade |
D&A For EBITDA | 0.31 | 0.4 | 0.5 | 0.59 | 0.7 | Upgrade |
EBIT | -21.66 | -45.12 | -96.97 | 18.97 | 109.95 | Upgrade |
EBIT Margin | -2.70% | -4.82% | -11.36% | 1.49% | 8.55% | Upgrade |
Effective Tax Rate | - | - | - | 39.03% | 14.38% | Upgrade |
Revenue as Reported | 807.02 | 941.19 | 864.27 | 1,277 | 1,296 | Upgrade |
Advertising Expenses | - | - | - | 0.01 | 0.01 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.